The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital

Background: Schizophrenia is a mental disorder that impacts behavior, emotions, and communication. In recent years, atypical antipsychotics have been increasingly prescribed because they significantly reduce both positive and negative symptoms. However, the long-term effects of atypical can cause me...

Full description

Saved in:
Bibliographic Details
Main Authors: Indah Kurnia Utami, Yasinta Rakanita, Patricia Novina Nurak, Niluh Puspita Dewi
Format: Article
Language:English
Published: Pusat Pengembangan Teknologi Informasi Dan Jurnal Universitas Muhammadiyah Palu 2024-11-01
Series:Journal of Public Health and Pharmacy
Subjects:
Online Access:https://jurnal.unismuhpalu.ac.id/index.php/jphp/article/view/5900
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823859540565688320
author Indah Kurnia Utami
Yasinta Rakanita
Patricia Novina Nurak
Niluh Puspita Dewi
author_facet Indah Kurnia Utami
Yasinta Rakanita
Patricia Novina Nurak
Niluh Puspita Dewi
author_sort Indah Kurnia Utami
collection DOAJ
description Background: Schizophrenia is a mental disorder that impacts behavior, emotions, and communication. In recent years, atypical antipsychotics have been increasingly prescribed because they significantly reduce both positive and negative symptoms. However, the long-term effects of atypical can cause metabolic syndrome. Additional therapy is provided to maximize the primary therapy and reduce the side effects. Method: This study used a quasi-experimental design with a single-blind, pretest-posttest approach. Patients who had been using atypical antipsychotics, either monotherapy or combination therapy, for more than 3 were examined pretest to determine metabolic syndrome levels. Group A received adjuvant therapy, while Group B did not receive adjuvant therapy. Based on this data, an analysis of the reduction in metabolic syndrome categories was conducted.   Result: The percentage of schizophrenia patients by gender was dominated by males (60%). By age, the majority were adults (87%). In Group A, the incidence of metabolic syndrome decreased from 53% in the pretest to 40% in the posttest after being given vitamin A, B, and folic acid therapy. The most commonly used other medication was THP (38%). Conclusion: The administration of adjuvant therapy with vitamins A, B, E, and folic acid can reduce the value of one or two of the five metabolic syndrome criteria for schizophrenia patients (p = 0.052) compared to the group of patients who did not receive vitamins A, B, E, and folic acid adjuvant therapy. Future research should use a longer duration to observe the effects of vitamins A, B, E, and folic acid and evaluate their therapeutic doses. Additionally, it should narrow down the criteria for medication use, focusing solely on the atypical antipsychotic’s clozapine or olanzapine.
format Article
id doaj-art-65c820779e3b4d258e6af91c0f216c3b
institution Kabale University
issn 2775-4952
language English
publishDate 2024-11-01
publisher Pusat Pengembangan Teknologi Informasi Dan Jurnal Universitas Muhammadiyah Palu
record_format Article
series Journal of Public Health and Pharmacy
spelling doaj-art-65c820779e3b4d258e6af91c0f216c3b2025-02-11T01:55:31ZengPusat Pengembangan Teknologi Informasi Dan Jurnal Universitas Muhammadiyah PaluJournal of Public Health and Pharmacy2775-49522024-11-014328028910.56338/jphp.v4i3.59005900The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani HospitalIndah Kurnia Utami0Yasinta Rakanita1Patricia Novina Nurak2Niluh Puspita Dewi3Faculty of Pharmacy, Pelita Mas College of Pharmacy, Sulawesi Tengah, IndonesiaFaculty of Pharmacy, Pelita Mas College of Pharmacy, Sulawesi Tengah, IndonesiaFaculty of Pharmacy, Pelita Mas College of Pharmacy, Sulawesi Tengah, IndonesiaFaculty of Pharmacy, Pelita Mas College of Pharmacy, Sulawesi Tengah, IndonesiaBackground: Schizophrenia is a mental disorder that impacts behavior, emotions, and communication. In recent years, atypical antipsychotics have been increasingly prescribed because they significantly reduce both positive and negative symptoms. However, the long-term effects of atypical can cause metabolic syndrome. Additional therapy is provided to maximize the primary therapy and reduce the side effects. Method: This study used a quasi-experimental design with a single-blind, pretest-posttest approach. Patients who had been using atypical antipsychotics, either monotherapy or combination therapy, for more than 3 were examined pretest to determine metabolic syndrome levels. Group A received adjuvant therapy, while Group B did not receive adjuvant therapy. Based on this data, an analysis of the reduction in metabolic syndrome categories was conducted.   Result: The percentage of schizophrenia patients by gender was dominated by males (60%). By age, the majority were adults (87%). In Group A, the incidence of metabolic syndrome decreased from 53% in the pretest to 40% in the posttest after being given vitamin A, B, and folic acid therapy. The most commonly used other medication was THP (38%). Conclusion: The administration of adjuvant therapy with vitamins A, B, E, and folic acid can reduce the value of one or two of the five metabolic syndrome criteria for schizophrenia patients (p = 0.052) compared to the group of patients who did not receive vitamins A, B, E, and folic acid adjuvant therapy. Future research should use a longer duration to observe the effects of vitamins A, B, E, and folic acid and evaluate their therapeutic doses. Additionally, it should narrow down the criteria for medication use, focusing solely on the atypical antipsychotic’s clozapine or olanzapine.https://jurnal.unismuhpalu.ac.id/index.php/jphp/article/view/5900adjuvantatypicalschizophrenia
spellingShingle Indah Kurnia Utami
Yasinta Rakanita
Patricia Novina Nurak
Niluh Puspita Dewi
The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital
Journal of Public Health and Pharmacy
adjuvant
atypical
schizophrenia
title The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital
title_full The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital
title_fullStr The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital
title_full_unstemmed The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital
title_short The Effect of Adjuvant Therapy on Metabolic Syndrome in Schizophrenia Patients at Madani Hospital
title_sort effect of adjuvant therapy on metabolic syndrome in schizophrenia patients at madani hospital
topic adjuvant
atypical
schizophrenia
url https://jurnal.unismuhpalu.ac.id/index.php/jphp/article/view/5900
work_keys_str_mv AT indahkurniautami theeffectofadjuvanttherapyonmetabolicsyndromeinschizophreniapatientsatmadanihospital
AT yasintarakanita theeffectofadjuvanttherapyonmetabolicsyndromeinschizophreniapatientsatmadanihospital
AT patricianovinanurak theeffectofadjuvanttherapyonmetabolicsyndromeinschizophreniapatientsatmadanihospital
AT niluhpuspitadewi theeffectofadjuvanttherapyonmetabolicsyndromeinschizophreniapatientsatmadanihospital
AT indahkurniautami effectofadjuvanttherapyonmetabolicsyndromeinschizophreniapatientsatmadanihospital
AT yasintarakanita effectofadjuvanttherapyonmetabolicsyndromeinschizophreniapatientsatmadanihospital
AT patricianovinanurak effectofadjuvanttherapyonmetabolicsyndromeinschizophreniapatientsatmadanihospital
AT niluhpuspitadewi effectofadjuvanttherapyonmetabolicsyndromeinschizophreniapatientsatmadanihospital